Taking a note from the Seattle Cancer Care Alliance blog:

Patient Power’s Andrew Schorr had the chance to catch up with SCCA’s Dr. John Pagel about advances in the treatment of chronic lymphocytic leukemia (CLL).

Dr. Pagel describes a whole new generation of promising and less toxic drugs that he describes as “clearly providing profound benefits for patients.”